Ferrán Rius
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 5
- Thyroid Disorders and Treatments 5
- Diabetes Management and Research 4
- Diabetes Treatment and Management 4
-
- Advanced Glycation End Products research 4
- Co-authors
- Marta Hernández (16 shared papers)Anna Sanmartı́ (6 shared papers)Dı́dac Mauricio (10 shared papers)Albert Lecube (13 shared papers)Jordi L. Reverter (3 shared papers)Enric Sánchez (11 shared papers)Irma Leticia Bazán Salinas (3 shared papers)Carolina López‐Cano (7 shared papers)
- Journals
- Nutrients (3 papers)PLoS ONE (3 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)The Lancet (2 papers)American Journal of Hematology (2 papers)
- Partner nations
- SpainItalyUnited Kingdom
In The Last Decade
Ferrán Rius
46 papers receiving 3.3k citations
Ferrán Rius's Hit Papers
Peers
Comparison fields: 5 of 102
- Endocrinology, Diabetes and Metabolism 2.5k
- Nephrology 142
- Pharmacology 325
- Cardiology and Cardiovascular Medicine 359
- Surgery 627
Countries citing papers authored by Ferrán Rius
This map shows the geographic impact of Ferrán Rius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferrán Rius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferrán Rius more than expected).
Fields of papers citing papers by Ferrán Rius
This network shows the impact of papers produced by Ferrán Rius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferrán Rius. The network helps show where Ferrán Rius may publish in the future.
Co-authors
The 25 scholars most cited alongside Ferrán Rius, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hit paper breakdown → | 2019 | 2307 |
| 2 | Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hit paper breakdown → | 2019 | 492 |
| 3 | 1999 | 70 | |
| 4 | 1997 | 59 | |
| 5 | 2013 | 51 | |
| 6 | 1997 | 39 | |
| 7 | 2014 | 34 | |
| 8 | 2018 | 31 | |
| 9 | 2019 | 25 | |
| 10 | 2018 | 22 | |
| 11 | 1995 | 19 | |
| 12 | 2003 | 19 | |
| 13 | 2017 | 18 | |
| 14 | 2019 | 17 | |
| 15 | 2019 | 15 | |
| 16 | 2019 | 14 | |
| 17 | 2020 | 14 | |
| 18 | 2020 | 13 | |
| 19 | 2018 | 12 | |
| 20 | 2019 | 12 |
About Ferrán Rius
Ferrán Rius is a scholar working on Endocrinology, Diabetes and Metabolism, Clinical Biochemistry, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging, having authored 50 papers that have together received 3.4k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Thyroid Disorders and Treatments (5 papers), Diabetes and associated disorders (4 papers), Diabetes Management and Research (4 papers), Advanced Glycation End Products research (4 papers), Diabetes Treatment and Management (4 papers), Cardiovascular Health and Disease Prevention (4 papers) and Nutritional Studies and Diet (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.5k citations), Nephrology (142 citations), Pharmacology (325 citations), Cardiology and Cardiovascular Medicine (359 citations) and Surgery (627 citations). Ferrán Rius has collaborated with scholars based in Spain, Italy and United Kingdom. Frequent co-authors include Marta Hernández, Anna Sanmartı́, Dı́dac Mauricio, Albert Lecube, Jordi L. Reverter, Enric Sánchez, Irma Leticia Bazán Salinas, Carolina López‐Cano, Joan Rubiés-Prat and Antoni Ordinas. Their work appears in journals such as Nutrients, PLoS ONE, International Journal of Radiation Oncology*Biology*Physics, The Lancet and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.